US 9315811
Methods for modulating kallikrein (KLKB1) expression
granted A61KA61K31/7125A61P
Quick answer
US patent 9315811 (Methods for modulating kallikrein (KLKB1) expression) held by Ionis Pharmaceuticals, Inc. expires Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Apr 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K31/7125, A61P, A61P7/10